The expression of Bcl-xl, Cyclin E, and PCNA with combined radotinib and Ara-C treatment was significantly decreased in tumor tissues isolated from the mice, as shown in Fig. 6d-e. This evidence concerns the gene BCL2L1 and neoplasm.